THE ART OF RISK COMMUNICATION Breast cancer screening pamphlets mislead women

被引：40
作者：
Gigerenzer, Gerd [1 ,2 ]
机构：
[1] Max Planck Inst Human Dev, Harding Ctr Risk Literacy, Berlin, Germany
[2] Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2014年 / 348卷
关键词：
BENEFITS;
D O I：
10.1136/bmj.g2636
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 5 条
[1]   Public Knowledge of Benefits of Breast and Prostate Cancer Screening in Europe [J].
Gigerenzer, Gerd ;
Mata, Jutta ;
Frank, Ronald .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (17) :1216-1220
[2]   Screening for breast cancer with mammography [J].
Gotzsche, Peter C. ;
Jorgensen, Karsten Juhl .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (06)
[3]   Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial [J].
Miller, Anthony B. ;
Wall, Claus ;
Baines, Cornelia J. ;
Sun, Ping ;
To, Teresa ;
Narod, Steven A. .
BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
[4]   Using a Drug Facts Box to Communicate Drug Benefits and Harms Two Randomized Trials [J].
Schwartz, Lisa M. ;
Woloshin, Steven ;
Welch, H. Gilbert .
ANNALS OF INTERNAL MEDICINE, 2009, 150 (08) :516-W93
[5]   Are increasing 5-year survival rates evidence of success against cancer? [J].
Welch, HG ;
Schwartz, LM ;
Woloshin, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (22) :2975-2978
1